BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15551877)

  • 61. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Pai H; Seo MR; Choi TY
    Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
    Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
    Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular characterization and epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in the United Arab Emirates.
    Alfaresi MS; Elkoush AA; Alshehhi HM; Abdulsalam AI
    Med Princ Pract; 2011; 20(2):177-80. PubMed ID: 21252576
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SHV-5 extended-spectrum beta-lactamase from Klebsiella pneumoniae associated with a nosocomial outbreak in a paediatric oncology unit in Malaysia.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Int J Infect Dis; 2005 May; 9(3):170-2. PubMed ID: 15840458
    [No Abstract]   [Full Text] [Related]  

  • 66. Investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases in a neonatal ward, Sousse, Tunisia.
    Bouallègue-Godet O; Grimont F; Ben Salem Y; Saidani M; Mzoughi R; Sboui H; Grimont PA
    Pathol Biol (Paris); 2005 Mar; 53(2):75-80. PubMed ID: 15708650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eradication of an extensive outbreak in a neonatal unit caused by two sequential Klebsiella pneumoniae clones harbouring related plasmids encoding an extended-spectrum beta-lactamase.
    Velasco C; Rodríguez-Baño J; García L; Díaz P; Lupión C; Durán L; Pascual A
    J Hosp Infect; 2009 Oct; 73(2):157-63. PubMed ID: 19716201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
    Treviño M; Navarro D; Barbeito G; García-Riestra C; Crespo C; Regueiro BJ
    Microb Drug Resist; 2011 Sep; 17(3):433-42. PubMed ID: 21568752
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.
    Romero ED; Padilla TP; Hernández AH; Grande RP; Vázquez MF; García IG; García-Rodríguez JA; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):433-7. PubMed ID: 17913435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
    Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Fishman NO; Bilker WB; Mao X; Lautenbach E
    Clin Infect Dis; 2005 May; 40(9):1317-24. PubMed ID: 15825035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland.
    Roche C; Boo TW; Walsh F; Crowley B
    Clin Microbiol Infect; 2008 Jun; 14(6):616-8. PubMed ID: 18397332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases.
    García San Miguel L; Cobo J; Valverde A; Coque TM; Diz S; Grill F; Cantón R
    Clin Microbiol Infect; 2007 May; 13(5):532-8. PubMed ID: 17263834
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
    Woodford N; Tierno PM; Young K; Tysall L; Palepou MF; Ward E; Painter RE; Suber DF; Shungu D; Silver LL; Inglima K; Kornblum J; Livermore DM
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4793-9. PubMed ID: 15561858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clonal spread of Klebsiella pneumoniae producing CMY-2 AmpC-type beta-lactamase in surgical intensive care units.
    Ko WC; Lee HC; Yan JJ; Wu JJ; Chang CM; Wu CJ; Lee NY; Chen PL; Lee CC
    J Microbiol Immunol Infect; 2009 Dec; 42(6):479-87. PubMed ID: 20422132
    [No Abstract]   [Full Text] [Related]  

  • 78. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
    Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The spread of KPC-3 Klebsiella pneumoniae in hospitals in Bogotá over a three-year period (2008-2010)].
    Rodríguez EC; Saavedra SY; Leal AL; Álvarez C; Olarte N; Valderrama A; Cuervo SI; Escobar J
    Biomedica; 2014 Apr; 34 Suppl 1():224-31. PubMed ID: 24968054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular epidemiology of ESBL-producing Klebsiella pneumoniae isolates in intensive care units of a tertiary care hospital, North of Iran.
    Ghaffarian F; Hedayati M; Sedigh Ebrahim-Saraie H; Atrkar Roushan Z; Mojtahedi A
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):75-79. PubMed ID: 29974849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.